TPICQ · As filed with the SEC
Tpi Composites cash flow statement, by quarter
The statement as Tpi Composites presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | Q4 2025 3 months ended Dec 31, 2025 | Q3 2025 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024 3 months ended Dec 31, 2024 | Q3 2024 3 months ended Sep 30, 2024 | Q2 2024 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Net loss | — | — | — | (48,313,000) | — | — | — | (61,468,000) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization | — | — | — | 6,889,000 | — | — | — | 8,900,000 |
| Loss on sale of assets and asset impairments | — | — | — | 2,549,000 | — | — | — | 1,492,000 |
| Share-based compensation expense | — | — | — | 1,220,000 | — | — | — | 2,589,000 |
| Amortization of debt issuance costs and debt discount | — | — | — | 8,475,000 | — | — | — | 7,713,000 |
| Paid-in-kind interest | — | — | — | 12,130,000 | — | — | — | 11,017,000 |
| Deferred income taxes | — | — | — | (3,351,000) | — | — | — | (2,273,000) |
| Changes in assets and liabilities: | ||||||||
| Accounts receivable | — | — | — | 17,599,000 | — | — | — | 7,657,000 |
| Contract assets and liabilities | — | — | — | (37,848,000) | — | — | — | 4,736,000 |
| Operating lease right of use assets and operating lease liabilities | — | — | — | 14,000 | — | — | — | 244,000 |
| Inventories | — | — | — | 1,974,000 | — | — | — | (5,469,000) |
| Prepaid expenses | — | — | — | 985,000 | — | — | — | (744,000) |
| Other current assets | — | — | — | 349,000 | — | — | — | (7,010,000) |
| Other noncurrent assets | — | — | — | 1,172,000 | — | — | — | (791,000) |
| Accounts payable and accrued expenses | — | — | — | 32,577,000 | — | — | — | (5,871,000) |
| Accrued warranty | — | — | — | 8,025,000 | — | — | — | 17,000 |
| Other noncurrent liabilities | — | — | — | 179,000 | — | — | — | 257,000 |
| Net cash used in operating activities | — | — | — | 4,625,000 | — | — | — | (39,004,000) |
| Cash flows from investing activities: | ||||||||
| Purchases of property, plant and equipment | — | — | — | (6,512,000) | — | — | — | (8,285,000) |
| Net cash used in investing activities | — | — | — | (6,512,000) | — | — | — | (8,285,000) |
| Cash flows from financing activities: | ||||||||
| Proceeds from working capital loans | — | — | — | 36,204,000 | — | — | — | 52,009,000 |
| Repayments of working capital loans | — | — | — | (56,690,000) | — | — | — | (44,556,000) |
| Principal repayments of finance leases | — | — | — | (248,000) | — | — | — | (297,000) |
| Repayments of other debt | — | — | — | (303,000) | — | — | — | — |
| Net proceeds from other debt | — | — | — | — | — | — | — | (1,635,000) |
| Proceeds from issuance of convertible notes | — | — | — | — | — | — | — | 0 |
| Purchase of capped calls | — | — | — | — | — | — | — | 0 |
| Payments of debt issuance costs | — | — | — | — | — | — | — | 0 |
| Repurchase of common stock including shares withheld in lieu of income taxes | — | — | — | (693,000) | — | — | — | (1,641,000) |
| Net cash provided by financing activities | — | — | — | (21,730,000) | — | — | — | 3,880,000 |
| Impact of foreign exchange rates on cash, cash equivalents and restricted cash | — | — | — | (973,000) | — | — | — | 333,000 |
| Net change in cash, cash equivalents and restricted cash | — | — | — | (24,590,000) | — | — | — | (43,076,000) |
| Cash, cash equivalents and restricted cash, beginning of year | 40,542,000 | 117,089,000 | 183,069,000 | 207,659,000 | 136,182,000 | 111,038,000 | 129,737,000 | 172,813,000 |
| Cash, cash equivalents and restricted cash, end of period | 24,590,000 | 40,542,000 | 117,089,000 | 183,069,000 | 207,659,000 | 136,182,000 | 111,038,000 | 129,737,000 |
| Supplemental cash flow information: | ||||||||
| Cash paid for interest | — | — | — | 6,534,000 | — | — | — | 4,799,000 |
| Cash paid for income taxes, net of refunds | — | — | — | 6,682,000 | — | — | — | 9,484,000 |
| Noncash investing and financing activities: | ||||||||
| Right of use assets obtained in exchange for new operating lease liabilities | — | — | — | 0 | — | — | — | 6,633,000 |
| Property, plant, and equipment obtained in exchange for new finance lease liabilities | — | — | — | 50,000 | — | — | — | 170,000 |
| Accrued capital expenditures in accounts payable | — | — | — | 1,359,000 | — | — | — | 4,381,000 |
| Paid-in-kind preferred stock dividends and accretion | — | — | — | — | — | — | — | 0 |
| Reconciliation of Cash, Cash Equivalents and Restricted Cash: | ||||||||
| Cash and cash equivalents | 29,500,000 | 106,419,000 | 171,859,000 | 196,518,000 | 80,911,000 | 101,861,000 | 116,850,000 | 161,059,000 |
| Cash and cash equivalents | — | 29,500,000 | 106,419,000 | 171,859,000 | — | 125,871,000 | 101,861,000 | — |
| Restricted cash | 10,124,000 | 9,798,000 | 9,695,000 | 9,639,000 | 9,576,000 | 8,451,000 | 12,035,000 | 10,838,000 |
| Restricted cash | — | 10,124,000 | 9,798,000 | 9,695,000 | — | 9,576,000 | 8,451,000 | — |
| Cash and cash equivalents of discontinued operations | 918,000 | 872,000 | 1,515,000 | 1,502,000 | 45,695,000 | 726,000 | 852,000 | 916,000 |
| Cash and cash equivalents of discontinued operations | — | 918,000 | 872,000 | 1,515,000 | — | 735,000 | 726,000 | — |
| Restricted cash of discontinued operations | — | — | — | — | — | — | — | 0 |
| Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows | 40,542,000 | 117,089,000 | 183,069,000 | 207,659,000 | 136,182,000 | 111,038,000 | 129,737,000 | 172,813,000 |
| Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows | — | 40,542,000 | 117,089,000 | 183,069,000 | — | 136,182,000 | 111,038,000 | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
